This is a product software upgrade announcement with no financial or guidance content — a routine operational update. Monitor upcoming quarterly filings for evidence of increased utilization or procedure volumes that could flow into revenue; no immediate trading catalyst.
Price Chart
Executive Summary
Profound Medical announced the introduction of its latest Treatment Delivery Console (TDC) software, which is being deployed across its TULSA-PRO installed base. The software adds real-time iMRI control and physician-requested UI improvements, with management stating it provides a roadmap for surgeons to achieve up to six TULSA procedures per day (up from a current reported capability of approximately four per day by some physicians). The filing contains no financial data, no guidance updates, and no preliminary results.
Key Facts
- Profound introduced a new TDC software update deployed across the installed TULSA-PRO base.
- Key new features: real-time iMRI control and physician-requested UI/hardware improvements.
- CEO stated the software provides a roadmap for surgeons to achieve up to 6 TULSA procedures per system per day; a 'few' physicians already report performing up to 4 per day.
- No financial figures, revenue guidance, or quantitative performance metrics were provided in the filing.
Financial Impact
No financial data provided in filing; potential for increased procedure throughput over time but no revenue impact disclosed.
Risk Factors
- No financial/guidance data to evaluate materiality; software roadmap may not achieve intended utilization gains.
- Competitive intensity in prostate ablation market may limit up-take or pricing power.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-005580 |
| Exhibit: exh_991.htm | 0001171843-26-005580 |
| Document: 0001171843-26-005580-index-headers.html | 0001171843-26-005580 |
| Document: 0001171843-26-005580-index.html | 0001171843-26-005580 |
| Document: 0001171843-26-005580.txt | 0001171843-26-005580 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $6.89 $5.81 | ▼ −15.67% | ▼ −14.47% | $5.85 (−15.09%) |
Sep 3, 2026 29d ago | 8-K | $6.80 $5.97 | ▼ −12.21% | ▼ −11.06% | $5.85 (−13.97%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Jul 24, 2026 10w ago | 8-K | $7.26 $7.25 | ▼ −0.14% | ▼ −0.51% | $5.85 (−19.42%) |
Jul 15, 2026 11w ago | 8-K | $6.96 $6.99 | ▲ +0.43% | ▲ +1.41% | $5.85 (−15.95%) |
May 14, 2026 20w ago | 8-K | $6.97 $6.83 | ▼ −2.01% | ▼ −2.97% | $5.85 (−16.07%) |
May 12, 2026 20w ago | S-3 | $7.10 $6.73 | ▼ −5.21% | ▼ −4.05% | $5.85 (−17.61%) |
Apr 16, 2026 24w ago | 8-K | $6.62 $6.75 | ▲ +1.96% | ▲ +0.98% | $5.85 (−11.63%) |
Apr 14, 2026 24w ago | 8-K | $6.26 $6.84 | ▲ +9.27% | ▲ +7.87% | $5.85 (−6.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access